Americas vs El Salvador: Proportion of the target population who received a 3rd dose of
Americas
79.0%
in 2024
El Salvador
96.0%
in 2024
Americas rank
14th
El Salvador rank
16th
Proportion of the target population who received a 3rd dose of over time
- Americas
- El Salvador
How they compare
El Salvador currently reports 96.0% against 79.0% in Americas, a difference of 17.0%.
That makes El Salvador's figure about 1.2 times Americas's.
Across all 15 years both countries report, El Salvador has been ahead every year.
Americas ranks 14th and El Salvador ranks 16th of 37 groups.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Americas | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.2% | 91.0% | 13.8% | El Salvador |
| 2020s | 76.4% | 94.0% | 17.6% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Americas or El Salvador?
- El Salvador, at 96.0% against 79.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Americas and El Salvador?
- 17.0%, with El Salvador ahead.
- How many years of comparable data are there for Americas and El Salvador?
- 15 years are reported by both, from 2010 to 2024.
- How do Americas and El Salvador rank globally for proportion of the target population who received a 3rd dose of?
- Americas ranks 14th and El Salvador ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.